# Orforglipron Half-Life: How Long It Stays in Your System

Source: https://pepvault.app/peptides/orforglipron/half-life

Last updated: 2026-10-06

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Library](https://pepvault.app/peptides) [Orforglipron](https://pepvault.app/peptides/orforglipron) Half-life

Peptide questions · Orforglipron

# Orforglipron half-life: how long it stays in your system

Reviewed October 2026 Evidence: Established [Published by PepVault](https://pepvault.app/guides/how-we-research)

Orforglipron’s half-life is about 1.2–2 days (29–49 hours), the figure on its drug label.

Half of a dose of orforglipron is gone after about 1.2–2 days, and about 97% after 6–10 days, five half-lives.

## How much orforglipron is left after each half-life

Each half-life halves whatever is left. Starting from one dose of orforglipron, about 50% remains after 1.2–2 days, 25% after 2.4–4.1 days and 12.5% after 3.6–6.1 days.

What is left of one dose of orforglipron, half-life by half-life

| Half-lives | Time after a dose | Left | Cleared |
| --- | --- | --- | --- |
| 1 | about 1.2–2 days | 50% | 50% |
| 2 | about 2.4–4.1 days | 25% | 75% |
| 3 | about 3.6–6.1 days | 12.5% | 87.5% |
| 4 | about 4.8–8.2 days | 6.3% | 93.8% |
| 5 | about 6–10 days | 3.1% | 96.9% |
| 7 | about 8.5–14 days | 0.8% | 99.2% |

What is left of one dose, half-life by half-life: an estimate from the stated figure.

By about 6–10 days (five half-lives) 96.9% of a single dose of orforglipron has cleared, and by about 8.5–14 days (seven) 99.2%. A day after a dose about 56.3–71.2% of it is still there.

This is elimination arithmetic: it describes how the level in the blood falls after a dose, not how long a drug test can find it, and this page makes no claim about detection.

The arithmetic assumes the body clears the compound at a steady rate, the simple one-compartment model the half-life calculator uses; absorption from under the skin, the route and the person all move the real curve.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Track orforglipron in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=q-half-life-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Orforglipron on a regular schedule

The library lists orforglipron’s frequency as “Daily”, a dose every 24 hours, which is 0.5–0.8 of its half-lives.

When the next dose of orforglipron comes, about 56.3–71.2% of the one before is still there, so the doses overlap and the level climbs over the first ones. It stops climbing after 4 to 5 half-lives, about 4.8–10 days, which on this schedule is about 5–11 doses. From then on each peak of orforglipron sits about 2.3–3.5 times as high as a single dose’s.

An estimate on the library’s typical schedule from the half-life above, not a measurement.

## More on orforglipron

### Orforglipron

- [Orforglipron: the full reference](https://pepvault.app/peptides/orforglipron)
- [Orforglipron dose guide](https://pepvault.app/lab/dosage/orforglipron)

### Studies

- [Orforglipron: heart events no worse than insulin in ACHIEVE-4](https://pepvault.app/research/orforglipron-achieve-4-2026)
- [Orforglipron: 9.6% weight loss at 72 weeks in ATTAIN-2](https://pepvault.app/research/orforglipron-attain-2-2026)
- [Semaglutide (oral): smaller HbA1c drop than orforglipron in ACHIEVE-3](https://pepvault.app/research/semaglutide-achieve-3-2026)
- [All 5 studies](https://pepvault.app/research#orforglipron)

### Compared with

- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Orforglipron vs Tirzepatide](https://pepvault.app/peptides/compare/orforglipron-vs-tirzepatide)
- [Orforglipron vs Semaglutide (oral)](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide-oral)
- [Retatrutide vs Orforglipron](https://pepvault.app/peptides/compare/retatrutide-vs-orforglipron)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Orforglipron questions

- [Orforglipron: side effects](https://pepvault.app/peptides/orforglipron/side-effects)
- [Orforglipron: how long it takes to work](https://pepvault.app/peptides/orforglipron/how-long-to-work)

### Terms on this page

- [Half-life](https://pepvault.app/glossary/half-life)
- [GLP-1](https://pepvault.app/glossary/glp-1)

## Orforglipron against other metabolic & GLP-1 compounds

The library states a half-life with a number for 20 of its metabolic & GLP-1 compounds. Orforglipron’s is the sixth shortest of the 20: the shortest is oxytocin at about 1–6 minutes, the longest eloralintide at about 14 days (336 hours).

Metabolic & GLP-1 compounds by half-life, shortest first

| Compound | Half-life | Kind of figure |
| --- | --- | --- |
| [Oxytocin](https://pepvault.app/peptides/oxytocin/half-life) | about 1–6 minutes | source not given |
| [Pramlintide](https://pepvault.app/peptides/pramlintide/half-life) | about 48 minutes | drug label |
| [Exenatide](https://pepvault.app/peptides/exenatide/half-life) | about 2.4 hours | drug label |
| [Setmelanotide](https://pepvault.app/peptides/setmelanotide/half-life) | about 11 hours | drug label |
| [Liraglutide](https://pepvault.app/peptides/liraglutide/half-life) | about 13 hours | source not given |
| Orforglipron | about 1.2–2 days (29–49 hours) | drug label |
| [Amycretin](https://pepvault.app/peptides/amycretin/half-life) | about 3.7 days (88 hours) | measured in people |
| [Dulaglutide](https://pepvault.app/peptides/dulaglutide/half-life) | about 5 days (120 hours) | drug label |
| [Tirzepatide](https://pepvault.app/peptides/tirzepatide/half-life) | about 5 days (120 hours) | drug label |
| [Ecnoglutide](https://pepvault.app/peptides/ecnoglutide/half-life) | about 5.5 days (132 hours) | measured in people |
| [Enicepatide](https://pepvault.app/peptides/enicepatide/half-life) | about 5.5 days (132 hours) | measured in people |
| [Retatrutide](https://pepvault.app/peptides/retatrutide/half-life) | about 6 days (144 hours) | measured in people |
| [Cagrilintide](https://pepvault.app/peptides/cagrilintide/half-life) | about 7 days (168 hours) | measured in people |
| [CagriSema](https://pepvault.app/peptides/cagrisema/half-life) | about 7 days (168 hours) | measured in people |
| [Semaglutide](https://pepvault.app/peptides/semaglutide/half-life) | about 7 days (168 hours) | drug label |
| [Semaglutide (oral)](https://pepvault.app/peptides/semaglutide-oral/half-life) | about 7 days (168 hours) | source not given |
| [VK2735](https://pepvault.app/peptides/vk2735/half-life) | about 9 days (216 hours) | measured in people |
| [Mazdutide](https://pepvault.app/peptides/mazdutide/half-life) | about 10 days (240 hours) | drug label |
| [Petrelintide](https://pepvault.app/peptides/petrelintide/half-life) | about 10 days (240 hours) | measured in people |
| [Eloralintide](https://pepvault.app/peptides/eloralintide/half-life) | about 14 days (336 hours) | measured in people |

## What the half-life explains about how often orforglipron is dosed

Spacing doses of orforglipron 0.5–0.8 half-lives apart means more than half of each dose is still there at the next one, which is why orforglipron builds up over its first weeks and then holds a fairly even level.

> The library’s timing note
>
> One tablet a day, any time, with or without food, swallowed whole (label). The label climbs from 0.8 mg to 2.5 mg and then 5.5 mg, at least 30 days per step, and may continue to 9, 14.5 or 17.2 mg by response and tolerability. Per the label, a missed dose is taken as soon as possible but never doubled, and after 7 or more missed days in a row the climb restarts at a lower dose.

## Where the orforglipron figure comes from

> As the library states it
>
> ~29–49 hours (FDA label; steady levels after about a week of daily tablets)

Orforglipron’s half-life comes from its drug label, the figure the regulator reviewed, measured in people in the studies behind the approval.

Our study page on how orforglipron moves through the body:

- [Orforglipron: food lowered drug exposure by 17.6% to 23.7% (clinical trial, human)](https://pepvault.app/research/orforglipron-ma-2024)

## Questions people ask

### What is the half-life of orforglipron?

Orforglipron’s half-life is about 1.2–2 days (29–49 hours), the figure on its drug label. Half of a dose of orforglipron is gone after about 1.2–2 days, and about 97% after 6–10 days, five half-lives.

### How long does orforglipron stay in your system?

By elimination arithmetic, about 96.9% of a single dose of orforglipron has cleared after five half-lives, about 6–10 days, and 99.2% after seven, about 8.5–14 days. That is how its level in the blood falls, not a drug-test detection window.

### How long does orforglipron take to reach steady state?

On the library’s schedule (Daily), orforglipron’s level stops climbing after 4 to 5 half-lives, about 4.8–10 days, or 5–11 doses.

### Is the half-life of orforglipron measured in people?

Orforglipron’s half-life comes from its drug label, the figure the regulator reviewed, measured in people in the studies behind the approval.

## More on orforglipron

- [Orforglipron: the full library page](https://pepvault.app/peptides/orforglipron)
- [Orforglipron dose guide](https://pepvault.app/lab/dosage/orforglipron)
- [Peptide half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [Half-life, in the glossary](https://pepvault.app/glossary/half-life)
- [Steady state, in the glossary](https://pepvault.app/glossary/steady-state)
- [Orforglipron: side effects](https://pepvault.app/peptides/orforglipron/side-effects)
- [Orforglipron: how long it takes to work](https://pepvault.app/peptides/orforglipron/how-long-to-work)

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=q-half-life-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Track orforglipron in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=q-half-life-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Track orforglipron in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=q-half-life-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## More on orforglipron

### Orforglipron

- [Orforglipron: the full reference](https://pepvault.app/peptides/orforglipron)
- [Orforglipron dose guide](https://pepvault.app/lab/dosage/orforglipron)

### Studies

- [Orforglipron: heart events no worse than insulin in ACHIEVE-4](https://pepvault.app/research/orforglipron-achieve-4-2026)
- [Orforglipron: 9.6% weight loss at 72 weeks in ATTAIN-2](https://pepvault.app/research/orforglipron-attain-2-2026)
- [Semaglutide (oral): smaller HbA1c drop than orforglipron in ACHIEVE-3](https://pepvault.app/research/semaglutide-achieve-3-2026)
- [All 5 studies](https://pepvault.app/research#orforglipron)

### Compared with

- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Orforglipron vs Tirzepatide](https://pepvault.app/peptides/compare/orforglipron-vs-tirzepatide)
- [Orforglipron vs Semaglutide (oral)](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide-oral)
- [Retatrutide vs Orforglipron](https://pepvault.app/peptides/compare/retatrutide-vs-orforglipron)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Orforglipron questions

- [Orforglipron: side effects](https://pepvault.app/peptides/orforglipron/side-effects)
- [Orforglipron: how long it takes to work](https://pepvault.app/peptides/orforglipron/how-long-to-work)

### Terms on this page

- [Half-life](https://pepvault.app/glossary/half-life)
- [GLP-1](https://pepvault.app/glossary/glp-1)

<!--promo-->

PepVault for iPhone

## Track orforglipron in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=q-half-life-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Orforglipron

- [Orforglipron in the library](https://pepvault.app/peptides/orforglipron)
- [Orforglipron: side effects](https://pepvault.app/peptides/orforglipron/side-effects)
- [Orforglipron: how long it takes to work](https://pepvault.app/peptides/orforglipron/how-long-to-work)

## Tools

- [Peptide half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [Peptide dosage calculator](https://pepvault.app/tools/peptide-dosage-calculator)

## The library

- [The peptide reference library](https://pepvault.app/peptides)
- [Peptide comparisons](https://pepvault.app/peptides/compare)
- [The peptide glossary](https://pepvault.app/glossary)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
